Nuclear Imaging

Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. 

(A) PET images of [68Ga]Ga-DOTA-ZCAM241 uptake at baseline and 3, 7, and 12 days after injection as inflammatory arthritis developed in single representative individual mouse. Images are normalized to SUV of 0.5 for direct comparison between time points. (B) CD69 immunofluorescence Sytox (Thermo Fisher Scientific) staining of joints of representative animals during matching time points.
News | PET Imaging
New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Mid-Winter Conference drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well and the role of artificial intelligence (AI) in nuclear medicine during its Feb. 1-3, 2024 meeting in Orlando, FL.
News | SNMMI
Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter Conference Focuses on Theranostics, AI, Diagnostic Imaging Innovations and Clinical Trials

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
The growing emphasis on personalized treatment plans based on a patient’s unique genetic profile and tumor characteristics aims to optimize treatment outcomes while minimizing side effects, and this technology is being used in pediatric oncology. Getty Images
Feature | Radiation Oncology | By Melinda Taschetta-Millane
Special Report: Radiation Oncology Takeaways from RSNA23

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
Under the new agreement, NorthStar will manufacture and distribute patient doses for ongoing Curadh Ac-225 clinical studies and provide Ac-225 for commercial use upon NorthStar’s submission of a Type II Drug Master File (DMF) to the FDA
News | Radiopharmaceuticals and Tracers
NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration Agreement for Development and Production of Actinium-225 (Ac-225)-based Therapeutic Radiopharmaceuticals for Treatment of Primary and Metastatic Solid Tumors

January 5, 2024 — NorthStar Medical Radioisotopes, LLC, a global innovator in development, production and ...

Time January 05, 2024
arrow
Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer
News | Radiology Business
Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth

December 14, 2023 — Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization ...

Time December 14, 2023
arrow
Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway (gadopiclenol) in the European Union
News | Contrast Media
The European Commission Grants Marketing Authorization to Bracco Imaging for Vueway (gadopiclenol) Contrast Agent in the European Union

December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions ...

Time December 11, 2023
arrow
Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry Services brand, at the 2023 Radiological Society of North America (RSNA) Meeting
News | Quality Assurance (QA)
Mirion Medical Introduces Instadose VUE Dosimeter at Radiological Society of North America (RSNA) Annual Meeting

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
A biomarker of norepinephrine deficiency in the heart may help to detect Lewy body diseases before symptoms appear
News | PET Imaging
PET Scans May Predict Parkinson’s Disease and Lewy Body Dementia in At-risk Individuals

November 8, 2023 — In a small study, researchers at the National Institutes of Health have found that positron emission ...

Time November 08, 2023
arrow
Elekta wins public tender to deliver several Harmony linear accelerators to help meet demand for cancer treatments
News | Linear Accelerators
Elekta Continues to Support Ukrainian Cancer Patients with Latest Radiation Therapy Equipment

October 25, 2023 — A new order for several Elekta Harmony linear accelerators (linacs) in Ukraine will complement the ...

Time October 25, 2023
arrow
Comprehensive restoration of legacy machine offers the opportunity for sustainable solution
News | Proton Therapy
IBA Plans Total System Restoration on its First-ever Proton Therapy Installation

October 23, 2023 — IBA, a world leader in particle accelerator technology and the world’s leading provider of proton ...

Time October 23, 2023
arrow
Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4
News | Radiopharmaceuticals and Tracers
Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

October 20, 2023 — Meilleur Technologies, Inc. announced a research collaboration agreement with the Alzheimer’s Disease ...

Time October 20, 2023
arrow
Human life-like in vitro model of radiation damage sustained to the lung opens an unprecedented window into the early disease process, and opportunities for drug development
News | Radiation Therapy
Human Lung Chip Leveraged to Faithfully Model Radiation-induced Lung Injury

October 19, 2023 — The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high ...

Time October 19, 2023
arrow
New company will advance Actinium-225 technologies
News | Radiopharmaceuticals and Tracers
ITM and CNL Announce the Launch of Actineer, a New Joint Venture in the Global Production of Actinium-225

October 18, 2023 —ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Canadian ...

Time October 18, 2023
arrow
A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fibroblast Activation Protein Inhibitors (FAPI) radiopharmaceutical diagnostics - [68Ga]FAPI-46 and outside-U.S. rights for [18F]FAPI-74
News | Radiopharmaceuticals and Tracers
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE) ...

Time October 11, 2023
arrow
68Ga-ABY-025 PET/CT and 18F-FDG PET/CT images at baseline with 18F-FDG PET/CT follow-up after 2 cycles of treatment in biopsy-confirmed HER2-positive disease
News | Breast Imaging
Whole-body PET/CT Predicts Response to HER2-targeted Therapy in Metastatic Breast Cancer Patients

October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...

Time October 11, 2023
arrow
Dr. Michael Butkus is Co-medical Director and Head of Proton Physics at the Dwoskin Proton Center at the Sylvester Comprehensive Cancer Center
Feature | Proton Therapy | By Christine Book
One on One … with Michael Butkus, PhD

A University of Miami Radiation Oncology department summary noted: “In radiation oncology, the art of patient care meets ...

Time October 11, 2023
arrow
Videos | Proton Therapy
VIDEO: Advancements in Proton Therapy

Tune in to ITN’s latest “One on One” video series with Michael Butkus, PhD, for insights into proton therapy ...

Time October 10, 2023
arrow
Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient outcomes
News | Radiology Business
GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

October 10, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...

Time October 10, 2023
arrow
POSLUMA (flotufolastat F 18) PET/CT image showing uptake in the prostate gland, consistent with primary prostate cancer.
News | Radiopharmaceuticals and Tracers
Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO

October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 05, 2023
arrow
Advancements in research, technology and partnerships are combining to enhance availability and access
Feature | Proton Therapy | By Christine Book
Targeting Cancer, Tracking Collaboration: A Progress Report on Proton Therapy

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now